Severe Covid patients had less access to monoclonal antibody therapy

New York, Feb 5 (IANS): Due to unequal distribution, people over the age 65 at the highest risk for severe Covid-19 have often been the least likely to receive monoclonal antibodies (mAbs), according to new research.

Monoclonal antibodies are very effective at treating mild to moderate…

Continue Reading

News Source:

Leave a comment